Skip to content
IGM Biosciences
About Us
Our Company
Leadership Team
IGM Platform
Our IGM Platform
Publications
Presentations
Pipeline & Programs
Pipeline
Imvotamab
IGM-2644
Investors & News
Join Us
Our Culture
Open Jobs
Contact Us
<
Back to Presentations
November 2019
Agonist and Bispecific IgM: Nature’s Approach to Highly Avid, Multivalent Antibodies
PEGS Europe – November, 2019
View Presentation